JPRN-UMIN000002188
Not yet recruiting
未知
Comparative study of efficacy and safety of Administering 4mg once daily and 2mg twice daily of silodosin in patients with benign prostatic hyperplasia - Comparative study of mode of administration of silodosin
JR Tokyo General Hospital0 sites100 target enrollmentAugust 1, 2009
Conditionsbenign prostatic hyperplasia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- benign prostatic hyperplasia
- Sponsor
- JR Tokyo General Hospital
- Enrollment
- 100
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Men who treated by the medicin that has possibility to influence the urination function 2\.prostatic cancer 3\.Urinary tract infection 4\.urolithiasis 5\.hepatic dysfunction, renal dysfunction, cardiac disease 6\.orthostatic hypotention 7\.Any other clinically relevant laboratory abnormality as judged by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Comparison of the efficacy and safety of administering of Tranexamic acid and Dexmedetomidine and Nitroglycerine in preventing bleeding and the quality of ?the surgical site during septorhinoplasty under general anesthesiaseptorhinoplasty.Nasal polypIRCT20141209020258N121Arak University of Medical Sciences105
Completed
Phase 4
Management of Mild to Moderate Facial Acne VulgarisCTRI/2021/04/033182Ashwini T100
Active, not recruiting
Phase 1
se of an antidiabetic drug (Empagliflozin) to lower the blood level of 1,5-anhydroglucitol in patients deficient in the glucose-6-phosphate transporter (GSD1b) and the phosphatase G6PC3, both of the endoplasmic reticulum, to treat their recurrent infections by normalizing their blood neutrophil counts. Neutrophils are the most abundant white blood cells in our blood that are essential to help fighting infections. 1,5-anhydroglucitol is a sugar derivative with no known function.(1) Severe Congenital Neutropenia type 4 (SNC4) due to a deficiency in G6PC3, a phosphatase of the endoplasmic also known a Ubiquitous glucose-6-phosphatase and (2) the neutropenia in Glycogen Storage Disease type 1b due to a deficiency in the glucose-6-phosphate transporter (G6PT / SLC37A4) of the endoplasmic reticulum.Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2018-004191-35-BECliniques universitaires Saint-Luc5
Active, not recruiting
Phase 1
Evaluation of the efficacy and safety of administering lidocaine spray in gastroscopies: A randomized clinical trial.Elective gastroscopyMedDRA version: 18.0 Level: LLT Classification code 10018047 Term: Gastroscopy System Organ Class: 100000004848Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]EUCTR2015-000923-10-ESBASQUE HEALTH SYSTEM552
Not yet recruiting
Phase 4
Effect of N-Acetyl Cysteine in Rheumatoid arthritisHealth Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvementCTRI/2024/03/063534Government Kilpauk Medical College